CAS 1849590-01-7

eFT-508

CAS: 1849590-01-7

Fórmula: C₁₇H₂₀N₆O₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 340.3797

Ref: IN-DA00ABRG

Tomivosertib

CAS: 1849590-01-7

Tomivosertib

Fórmula: C₁₇H₂₀N₆O₂

Pureza: ≥95%

Peso molecular: 340.38

Ref: 54-BUP07402

eFT508

CAS: 1849590-01-7

eFT508

Fórmula: C₁₇H₂₀N₆O₂

Pureza: 98.8% (Typical Value in Batch COA)

Forma y color: Solid

Peso molecular: 340.37969

Ref: 54-BISN0203

Tomivosertib

CAS: 1849590-01-7

6'-((6-Aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione

Fórmula: C₁₇H₂₀N₆O₂

Pureza: 98%

Peso molecular: 340.38

Ref: IN-DG756354

Tomivosertib

CAS: 1849590-01-7

Tomivosertib (eFT508) is a potent, highly selective MNK1 and MNK2 inhibitor with IC50 value of 1-2 nM.

Fórmula: C₁₇H₂₀N₆O₂

Pureza: 98.42% - 99.72%

Forma y color: Solid

Peso molecular: 340.38

Ref: TM-T3468

6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione

Producto controlado

CAS: 1849590-01-7

Applications 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione was used in the study of inhibitors of immune checkpoint modulators and related methods. eFT508 is a potent, highly selective, and orally bioavailable MNK1 and MNK2 inhibitor.
References Webster, K., et al.: U.S. Pat. Appl. Publ. (2016), US 20160303124 A1 20161020; Webster, K., et al.: Blood, 126, 1554 (2015);

Fórmula: C₁₇H₂₀N₆O₂

Forma y color: Neat

Peso molecular: 340.38

Ref: TR-A629153

eFT 508

CAS: 1849590-01-7

Dual inhibitor of MNK1/2 (regulators of mRNA translation)

Fórmula: C₁₇H₂₀N₆O₂

Pureza: Min. 95%

Peso molecular: 340.38 g/mol

Ref: 3D-BE168437